EirGenix Financials
| 6589 Stock | TWD 89.00 0.80 0.91% |
EirGenix |
Understanding current and past EirGenix Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EirGenix's financial statements are interrelated, with each one affecting the others. For example, an increase in EirGenix's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in EirGenix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EirGenix. Check EirGenix's Beneish M Score to see the likelihood of EirGenix's management manipulating its earnings.
EirGenix Stock Summary
EirGenix competes with Elan Microelectronics, Oceanic Beverages, Ambassador Hotel, Chung Lien, and Landis Taipei. EirGenix Inc. operates as a contract development and manufacturing company worldwide. Its services include cell line development, process development, analytical sciences and quality control, cGMP manufacturing, and antibody drug conjugate. EIRGENIX INC operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 179 people.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0006589005 |
| Business Address | No 101, Kangning |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.eirgenix.com |
| Phone | 886 2 7708 0123 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in EirGenix without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of EirGenix Stock, because this is throwing your money away. Analyzing the key information contained in EirGenix's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
EirGenix Key Financial Ratios
There are many critical financial ratios that EirGenix's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that EirGenix reports annually and quarterly.| Return On Equity | -5.0E-4 | |||
| Return On Asset | -0.0168 | |||
| Target Price | 174.5 | |||
| Number Of Employees | 20 | |||
| Beta | 0.71 |
EirGenix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EirGenix's current stock value. Our valuation model uses many indicators to compare EirGenix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EirGenix competition to find correlations between indicators driving EirGenix's intrinsic value. More Info.EirGenix is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EirGenix's earnings, one of the primary drivers of an investment's value.EirGenix Systematic Risk
EirGenix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EirGenix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on EirGenix correlated with the market. If Beta is less than 0 EirGenix generally moves in the opposite direction as compared to the market. If EirGenix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EirGenix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EirGenix is generally in the same direction as the market. If Beta > 1 EirGenix moves generally in the same direction as, but more than the movement of the benchmark.
EirGenix November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EirGenix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of EirGenix. We use our internally-developed statistical techniques to arrive at the intrinsic value of EirGenix based on widely used predictive technical indicators. In general, we focus on analyzing EirGenix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EirGenix's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.62 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 10.84 | |||
| Value At Risk | (2.01) | |||
| Potential Upside | 2.75 |
Additional Tools for EirGenix Stock Analysis
When running EirGenix's price analysis, check to measure EirGenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EirGenix is operating at the current time. Most of EirGenix's value examination focuses on studying past and present price action to predict the probability of EirGenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EirGenix's price. Additionally, you may evaluate how the addition of EirGenix to your portfolios can decrease your overall portfolio volatility.